Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Journal of the Egyptian National Cancer Institute. 1996; 8 (1): 97-106
in English | IMEMR | ID: emr-41528
2.
Journal of the Egyptian National Cancer Institute. 1995; 7 (2): 199-205
in English | IMEMR | ID: emr-106374

ABSTRACT

Serum osteocalcin, a modern and sensitive marker of bone turnover, was measured in 60 female breast cancer patients and 8 healthy subjects as control. Patients were subdivided into 3 groups: The first group [group A] included postmastectomy patients in complete clinical remission, the second group [group B] involved those with visceral metastases or extraosseous metastases, while the third group [group C] represented those with bone metastases +/- extraosseous metastases. It was concluded that serum osteocalcin level increased in breast cancer patients with bone metastase, but decreased in those with visceral metastases. Also, it may be more important in evaluating bone metastases in breast cancer patients than serum alkaline phosphatase


Subject(s)
Humans , Female , Breast Neoplasms/secondary , Neoplasm Metastasis , Osteocalcin/blood , Bone Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL